Condition
Post Stroke Upper Limb Spasticity
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
3 treatments under study, led by Hu014 Inj
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
Phase 1 (1)
Phase 3 (1)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07340034Not ApplicableCompleted
Effects of Focal Muscle Vibration Versus Whole Upper Limb Vibration in Post-Stroke Patients
NCT05289921Phase 3CompletedPrimary
To Evaluate HU-014 in the Treatment of Post Stroke Upper Limb
NCT04415346Phase 1UnknownPrimary
A Single Center, Phase I Clinical Trial to Evaluate the Safety of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity
Showing all 3 trials
Research Network
Common Treatments
- Hu014 Inj2
- Focal Muscle Vibration Through Focal Muscle Vibrator Along With Conventional Neurorehabilitation1
- Upper Limb Vibration Through Whole Body Vibrator Along With Conventional Neurorehabilitation1
Active Sponsors
- Huons Co., Ltd.2
- Lahore University of Biological and Applied Sciences1
Top Investigators
Department of Physical Medicine&Rehabilitation
Related Conditions
- Stroke1